EUVIMEDSkopri EUVIMED
Open access

Rethinking Digital Outcome Measures for Amyotrophic Lateral Sclerosis Trials: Consensus Priorities for Actigraphy Harmonization, Validation, and Regulatory Readiness

Frederik Steyn, Rakesh Pilkar, Nadia Sethi, Lori Heller, Cory Holdom, Ruben P A van Eijk, Marcin Straczkiewicz, Katherine M Burke, James D Berry, Sanjay Chandriani, Gordon Jewett, Emma Hodson-Tole and 3 more

Journal of Medical Internet Research · 2026-11-12 · 28 · e106677-e106677

DOI: 10.2196/106677 ↗

At a glance

Journal article in Journal of Medical Internet Research, published online on 2026-11-12. Written by Frederik Steyn and 14 co-authors. Institution: UQ Centre for MND Research, School of Biomedical Sciences, The University of Queensland, Research Road, St Lucia, Brisbane, Queensland, 4072, Austral…. Major MEDLINE topics: Amyotrophic Lateral Sclerosis, Actigraphy, Outcome Assessment, Health Care, Clinical Trials as Topic. 35 references. The full text is freely available in PubMed Central.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Amyotrophic lateral sclerosis (ALS) clinical trials need outcome measures that complement established end points while capturing how people function in daily life. In this viewpoint, we draw on our collective experience in ALS research, clinical trials, digital-measure development, and regulatory science, together with published evidence, a preliminary patient survey, stakeholder discussions, and experience from multisite actigraphy studies. We argue that the field now has a substantial base of longitudinal data and candidate measures, but lacks the coordinated framework needed to compare, prioritize, and validate them across studies. We identify 4 linked priorities: adopt fit-for-purpose measures in stages and within defined contexts of use; harmonize data collection and analysis; use data to shortlist and validate measures across cohorts; and prepare actigraphy methods for trial adoption through early industry and regulatory engagement. Across these priorities, actigraphy should complement rather than replace established clinical outcomes, with its integration guided by patient relevance, ALS phenotypic heterogeneity, participant, and caregiver burden, and the intended context of use. Our central message is that progress now depends less on generating additional isolated datasets or measures than on coordinating the evaluation of existing assets, and aligning future evidence generation.

Subjects

MeSH terms (MEDLINE)

Amyotrophic Lateral SclerosisActigraphyOutcome Assessment, Health CareClinical Trials as TopicHumansConsensusDigital Health

Author keywords

accelerometryactigraphyamyotrophic lateral sclerosisclinical trial designdigital clinical outcome assessmentspatient-centered outcomesregulatory pathways

Authors and institutions

  • UQ Centre for MND Research, School of Biomedical Sciences, The University of Queensland, Research Road, St Lucia, Brisbane, Queensland, 4072, Australia, 61 0414653551.
  • Ametris, Pensacola, FL, United States.
  • North Star ALS, Santa Barbara, CA, United States.
  • Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, England, United Kingdom.
  • Department of Neurology & Biostatistics, University Medical Center Utrecht, Utrecht, The Netherlands.
  • AGH University of Krakow, Krakow, Poland.

Cite

APA

Steyn, F., Pilkar, R., Sethi, N., Heller, L., Holdom, C., van Eijk, R. P. A., Straczkiewicz, M., Burke, K. M., Berry, J. D., Chandriani, S., Jewett, G., Hodson-Tole, E., Hovinga, C., Vieira, F., & Guo, C. (2026). Rethinking Digital Outcome Measures for Amyotrophic Lateral Sclerosis Trials: Consensus Priorities for Actigraphy Harmonization, Validation, and Regulatory Readiness. Journal of Medical Internet Research, 28, e106677-e106677. https://doi.org/10.2196/106677

Vancouver

Steyn F, Pilkar R, Sethi N, Heller L, Holdom C, van Eijk RPA, et al. Rethinking Digital Outcome Measures for Amyotrophic Lateral Sclerosis Trials: Consensus Priorities for Actigraphy Harmonization, Validation, and Regulatory Readiness. Journal of Medical Internet Research. 2026;28:e106677-e106677. doi:10.2196/106677

BibTeX
@article{Steyn2026,
  author = {Steyn, Frederik and Pilkar, Rakesh and Sethi, Nadia and Heller, Lori and Holdom, Cory and van Eijk, Ruben P A and Straczkiewicz, Marcin and Burke, Katherine M and Berry, James D and Chandriani, Sanjay and Jewett, Gordon and Hodson-Tole, Emma and Hovinga, Collin and Vieira, Fernando and Guo, Christine},
  title = {Rethinking Digital Outcome Measures for Amyotrophic Lateral Sclerosis Trials: Consensus Priorities for Actigraphy Harmonization, Validation, and Regulatory Readiness},
  journal = {Journal of Medical Internet Research},
  year = {2026},
  volume = {28},
  pages = {e106677--e106677},
  doi = {10.2196/106677}
}
Start for free →